Longterm efficacy and safety of two short standardised regimens for the treatment of rifampicinresistant tuberculosis STREAM stage 2 extended followup of an openlabel multicentre randomised noninferiority trial

Abstract

Description

Keywords

Citation

WOS

Endorsement

Review

Supplemented By

Referenced By